(0.12%) 5 303.27 points
(0.34%) 40 004 points
(-0.07%) 16 686 points
(-0.14%) $79.95
(0.91%) $2.65
(0.58%) $2 431.50
(2.77%) $32.13
(0.33%) $1 093.60
(0.00%) $0.920
(-0.10%) $10.66
(0.04%) $0.787
(0.09%) $91.05
Live Chart Being Loaded With Signals
Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics...
Stats | |
---|---|
Dagens volum | 1.03M |
Gjennomsnittsvolum | 846 530 |
Markedsverdi | 13.60B |
EPS | $0 ( 2024-05-09 ) |
Neste inntjeningsdato | ( $1.150 ) 2024-08-06 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 74.99 |
ATR14 | $0.0600 (0.05%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-01 | Vandebroek Sophie V. | Buy | 1 218 | Common Stock |
2024-05-01 | Vandebroek Sophie V. | Buy | 977 | Common Stock |
2024-05-01 | Barrett Peter | Buy | 1 218 | Common Stock |
2024-05-01 | Barrett Peter | Buy | 977 | Common Stock |
2024-05-01 | Witz Pascale | Buy | 1 218 | Common Stock |
INSIDER POWER |
---|
44.21 |
Last 69 transactions |
Buy: 359 333 | Sell: 139 224 |
Volum Korrelasjon
Revvity, Inc. Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Revvity, Inc. Korrelasjon - Valuta/Råvare
Revvity, Inc. Økonomi
Annual | 2023 |
Omsetning: | $2.75B |
Bruttogevinst: | $1.17B (42.70 %) |
EPS: | $1.440 |
FY | 2023 |
Omsetning: | $2.75B |
Bruttogevinst: | $1.17B (42.70 %) |
EPS: | $1.440 |
FY | 2022 |
Omsetning: | $3.31B |
Bruttogevinst: | $1.99B (60.08 %) |
EPS: | $4.51 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Revvity, Inc.
Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.